MEASUREMENT OF TISSUE FACTOR PATHWAY INHIBITOR IN NORMAL AND POSTHEPARIN PLASMA

被引:24
作者
HUBBARD, AR
WELLER, LJ
GRAY, E
机构
[1] Division of Haematology, Nat. Inst. Biol. Standards Control, Potters Bar, Hertfordshire EN6 3QG, Blanch Lane, South Mimms
关键词
BLOOD COAGULATION; TISSUE FACTOR PATHWAY INHIBITOR; HEPARIN;
D O I
10.1097/00001721-199410000-00020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Assay methods for the detection of both tissue factor pathway inhibitor (TFPI) function (two-stage chromogenic assay) and for TFPI antigen levels (competitive ELISA) have been developed and applied to the measurement of TFPI in normal plasma, in post-heparin plasma and to recombinant TFPI. There was good correlation in TFPI levels, measured using the two methods (r = 0.848; P < 0.001) in the normal plasma samples (n = 21) with the values ranging from 0.6 to 1.4 units per ml relative to a normal reference plasma pool(assigned 1.0 unit per ml). The post-heparin plasma samples were associated with increased levels of both TFPI functional activity and antigen. However, there was poor correlation between the two methods, with an increase in antigen levels greatly exceeding the increase in functional activity. This discrepancy was also found with recombinant TFPI and may reflect the different responses of the two assay methods to lipoprotein-bound TFPI (in the normal plasma reference) and the 'free' TFPI in post-heparin plasma and recombinant TFPI. These findings have implications in the choice of suitable reference materials for the assay of TFPI.
引用
收藏
页码:819 / 823
页数:5
相关论文
共 13 条
[1]  
FINNEY DJ, 1978, STATISTICAL METHODS
[2]   INHIBITION OF THE TISSUE FACTOR-FACTOR-VII COMPLEX - INVOLVEMENT OF FACTOR XA AND LIPOPROTEINS [J].
HUBBARD, AR ;
JENNINGS, CA .
THROMBOSIS RESEARCH, 1987, 46 (04) :527-537
[3]   TISSUE FACTOR PATHWAY INHIBITOR WITH HIGH ANTICOAGULANT ACTIVITY IS INCREASED IN POSTHEPARIN PLASMA AND IN PLASMA FROM CANCER-PATIENTS [J].
LINDAHL, AK ;
JACOBSEN, PB ;
SANDSET, PM ;
ABILDGAARD, U .
BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (06) :713-721
[4]  
LINDAHL AK, 1991, THROMB RES, P39
[5]   THE C-TERMINUS OF TISSUE FACTOR PATHWAY INHIBITOR IS ESSENTIAL TO ITS ANTICOAGULANT ACTIVITY [J].
NORDFANG, O ;
BJORN, SE ;
VALENTIN, S ;
NIELSEN, LS ;
WILDGOOSE, P ;
BECK, TC ;
HEDNER, U .
BIOCHEMISTRY, 1991, 30 (43) :10371-10376
[6]  
NORDFANG O, 1993, THROMB HAEMOSTASIS, V70, P448
[7]  
NOVOTNY WF, 1991, BLOOD, V78, P394
[8]  
NOVOTNY WF, 1991, BLOOD, V78, P387
[9]  
NOVOTNY WF, 1989, J BIOL CHEM, V264, P18832
[10]   HEPARIN INDUCES RELEASE OF EXTRINSIC COAGULATION PATHWAY INHIBITOR (EPI) [J].
SANDSET, PM ;
ABILDGAARD, U ;
LARSEN, ML .
THROMBOSIS RESEARCH, 1988, 50 (06) :803-813